Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

NCT04803201

Conditions
Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Follicular T-Cell Lymphoma, +16 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 96 locations
View Trial Details
Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

NCT07586618

Conditions
Acute Lymphoblastic Leukemia ALL, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

NCT06561347

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute (CBCI) Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT04546399

Conditions
Abnormalities, Multiple, Burkitt Lymphoma, Chromosome Disorders, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
View all 227 locations
View Trial Details
Recruiting

A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain

NCT07029737

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site A Coruña, Spain
  • Research Site Alcorcón, Spain
  • Research Site Badalona, Spain
  • Research Site Barcelona, Spain
View all 22 locations
View Trial Details
Recruiting

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

NCT07332507

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View Trial Details

Related conditions